SEC Form 4 · accession 0001127602-17-025062
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher Causey
Director
Period of report
Aug 3, 2017
Accepted (ET)
Aug 7, 2017 · 8:46 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 3, 2017 | M | 750 | $54.77 | A | 4,625 | D | |
| Common Stock | Aug 3, 2017 | D | 750 | $126.96 | D | 3,875 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Tracking Award | $54.77 | Aug 3, 2017 | M | 750 | D | Jun 29, 2012 | Jun 29, 2021 | Common Stock | 750 | 9,000 | D |
Explanation of responses
- F1This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.